Therapy-Induced Modulation of the Tumor Microenvironment: New Opportunities for Cancer Therapies
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapy-Induced Modulation of the Tumor Microenvironment: New Opportunities for Cancer Therapies
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-10-23
DOI
10.3389/fonc.2020.582884
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor Immunology and Tumor Evolution: Intertwined Histories
- (2020) Jérôme Galon et al. IMMUNITY
- Time to dissect the autoimmune etiology of cancer antibody immunotherapy
- (2020) Michael Dougan et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
- (2020) Merry Jennifer Markham et al. JOURNAL OF CLINICAL ONCOLOGY
- Epigenetic therapy inhibits metastases by disrupting premetastatic niches
- (2020) Zhihao Lu et al. NATURE
- B cells and tertiary lymphoid structures promote immunotherapy response
- (2020) Beth A. Helmink et al. NATURE
- Combining microenvironment normalization strategies to improve cancer immunotherapy
- (2020) Fotios Mpekris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD73 blockade promotes dendritic cell infiltration of irradiated tumors and tumor rejection
- (2020) Erik Wennerberg et al. Cancer Immunology Research
- Methodological Development of Combination Drug and Radiation Therapy in Basic and Clinical Research
- (2020) Cyrus Chargari et al. CLINICAL CANCER RESEARCH
- Radiotherapy-Activated Hafnium Oxide Nanoparticles Produce Abscopal Effect in a Mouse Colorectal Cancer Model
- (2020) Ping Zhang et al. International Journal of Nanomedicine
- Radiation Damage to Tumor Vasculature Initiates a Program that Promotes Tumor Recurrences
- (2020) J. Martin Brown INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Toll-Like Receptor Agonists and Radiation Therapy Combinations: An Untapped Opportunity to Induce Anticancer Immunity and Improve Tumor control
- (2020) Richard C. Walshaw et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Dendritic Cell Maturation Defines Immunological Responsiveness of Tumors to Radiation Therapy
- (2020) Tiffany C. Blair et al. JOURNAL OF IMMUNOLOGY
- Polygenic risk for skin autoimmunity impacts immune checkpoint blockade in bladder cancer
- (2020) Zia Khan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Image‐guided tumor surgery: The emerging role of nanotechnology
- (2020) Nicholas E. Wojtynek et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Author Correction: Increased stiffness of the tumor microenvironment in colon cancer stimulates cancer associated fibroblast-mediated prometastatic activin A signaling
- (2020) Jessica Bauer et al. Scientific Reports
- The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
- (2020) Florent Petitprez et al. Frontiers in Immunology
- Forging New Strategies in the Cure of Human Oligometastatic Cancer
- (2020) Carlo Greco et al. JAMA Oncology
- Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer
- (2020) Ryan Phillips et al. JAMA Oncology
- Radiation and In-Situ Tumor Vaccination
- (2020) Encouse B. Golden et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Use of Multi-Site Radiation Therapy as Systemic Therapy: A New Treatment Approach Personalized by Patient Immune Status
- (2020) Roshal R. Patel et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Moving Immune Therapy Forward Targeting TME
- (2020) Kayla F Goliwas et al. PHYSIOLOGICAL REVIEWS
- Clarification of Definitions of Hyperprogressive Disease During Immunotherapy for Non–Small Cell Lung Cancer
- (2020) Baptiste Kas et al. JAMA Oncology
- Toward Systems Biomarkers of Response to Immune Checkpoint Blockers
- (2020) Óscar Lapuente-Santana et al. Frontiers in Oncology
- The interactions and communications in tumor resistance to radiotherapy: Therapy perspectives
- (2020) Milad Ashrafizadeh et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Cytoreduction and the Optimization Of Immune Checkpoint Inhibition with Radiation Therapy
- (2020) Stanley I. Gutiontov et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Future of Radiation and Immunotherapy
- (2020) Silvia C. Formenti et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47−mediated ‘don’t-eat-me’ signal
- (2019) Mingen Liu et al. NATURE IMMUNOLOGY
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer
- (2019) Ivy X. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Brian I. Rini et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity
- (2019) Kim Vriens et al. NATURE
- Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial
- (2019) Vicky Makker et al. LANCET ONCOLOGY
- Hyperspectral imaging for resection margin assessment during cancer surgery
- (2019) Esther Kho et al. CLINICAL CANCER RESEARCH
- Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges
- (2019) John D. Martin et al. Annual Review of Physiology
- Metabolic remodeling contributes towards an immune-suppressive phenotype in glioblastoma
- (2019) Pravin Kesarwani et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
- (2019) Daniel R. Gomez et al. JOURNAL OF CLINICAL ONCOLOGY
- CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
- (2019) Weimin Wang et al. NATURE
- Stress responses in stromal cells and tumor homeostasis
- (2019) Ilio Vitale et al. PHARMACOLOGY & THERAPEUTICS
- PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
- (2019) Takahiro Kamada et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT
- (2019) Marie-Nicole Theodoraki et al. OncoImmunology
- Targeting CXCL12/CXCR4 and myeloid cells to improve the therapeutic ratio in patient-derived cervical cancer models treated with radio-chemotherapy
- (2019) Magali Lecavalier-Barsoum et al. BRITISH JOURNAL OF CANCER
- Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic Cancer
- (2019) Alex B. Blair et al. CLINICAL CANCER RESEARCH
- Clonal replacement of tumor-specific T cells following PD-1 blockade
- (2019) Kathryn E. Yost et al. NATURE MEDICINE
- Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system
- (2019) Claire Lhuillier et al. Genome Medicine
- Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non–Small Cell Lung Cancer
- (2019) Joshua M. Bauml et al. JAMA Oncology
- Multiplex quantitative analysis of cancer-associated fibroblasts and immunotherapy outcome in metastatic melanoma
- (2019) Pok Fai Wong et al. Journal for ImmunoTherapy of Cancer
- Macrophage Exclusion after Radiation Therapy (MERT): A First in Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma
- (2019) Reena P Thomas et al. CLINICAL CANCER RESEARCH
- Integration of radiotherapy and immunotherapy for treatment of oligometastases
- (2019) Sean P Pitroda et al. LANCET ONCOLOGY
- NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial
- (2019) Sylvie Bonvalot et al. LANCET ONCOLOGY
- Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy
- (2019) Eric Deutsch et al. LANCET ONCOLOGY
- Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy
- (2019) Hari Menon et al. Journal for ImmunoTherapy of Cancer
- Post-ablation modulation after single high-dose radiation therapy improves tumor control via enhanced immunomodulation.
- (2019) Talicia Savage et al. CLINICAL CANCER RESEARCH
- Harnessing innate immunity in cancer therapy
- (2019) Olivier Demaria et al. NATURE
- Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
- (2019) Robert D. Leone et al. SCIENCE
- Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence
- (2019) Chanyoung Song et al. Nature Communications
- B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma
- (2019) Johannes Griss et al. Nature Communications
- Tumor-reprogrammed resident T cells resist radiation to control tumors
- (2019) Ainhoa Arina et al. Nature Communications
- Epithelial to mesenchymal plasticity and differential response to therapies in pancreatic ductal adenocarcinoma
- (2019) Rebecca L. Porter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypoxic tumor-derived exosomal miR-301a mediates M2 macrophage polarization via PTEN/PI3Kγ to promote pancreatic cancer metastasis
- (2018) Xiaofeng Wang et al. CANCER RESEARCH
- The Immune Landscape of Cancer
- (2018) Vésteinn Thorsson et al. IMMUNITY
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
- (2018) Dai Fukumura et al. Nature Reviews Clinical Oncology
- Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
- (2018) Mark A. Socinski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy
- (2018) Kaiyuan Ni et al. Nature Communications
- Positive Surgical Margins in the 10 Most Common Solid Cancers
- (2018) Ryan K. Orosco et al. Scientific Reports
- Image-guided surgery using near-infrared Turn-ON fluorescent nanoprobes for precise detection of tumor margins
- (2018) Rachel Blau et al. Theranostics
- Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy
- (2018) Soumaya Kouidhi et al. Frontiers in Immunology
- The Origin and Functions of Exosomes in Cancer
- (2018) Chitra Rajagopal et al. Frontiers in Oncology
- Complementary Molecular and Elemental Mass Spectrometric Imaging of Human Brain Tumors Resected by Fluorescence-Guided Surgery
- (2018) Sabrina Kröger et al. ANALYTICAL CHEMISTRY
- Organ-specific response to nivolumab in patients with non-small cell lung cancer (NSCLC)
- (2018) Sabine Schmid et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- PD-1 Inhibitor Immune-Related Adverse Events in Patients with Preexisting Endocrine Autoimmunity
- (2018) Halis Kaan Akturk et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
- (2018) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor-Stroma Mechanics Coordinate Amino Acid Availability to Sustain Tumor Growth and Malignancy
- (2018) Thomas Bertero et al. Cell Metabolism
- Long-Term Survival in Patients Responding to Anti–PD-1/PD-L1 Therapy and Disease Outcome upon Treatment Discontinuation
- (2018) Marie-Léa Gauci et al. CLINICAL CANCER RESEARCH
- miR-454-3p Is an Exosomal Biomarker and Functions as a Tumor Suppressor in Glioma
- (2018) Naiyuan Shao et al. MOLECULAR CANCER THERAPEUTICS
- Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
- (2018) Rodabe N. Amaria et al. NATURE MEDICINE
- Radiotherapy induces responses of lung cancer to CTLA-4 blockade
- (2018) Silvia C. Formenti et al. NATURE MEDICINE
- Hyperprogressive disease: recognizing a novel pattern to improve patient management
- (2018) Stéphane Champiat et al. Nature Reviews Clinical Oncology
- Time to abandon single-site irradiation for inducing abscopal effects
- (2018) Eric D. Brooks et al. Nature Reviews Clinical Oncology
- Turning foes to friends: targeting cancer-associated fibroblasts
- (2018) Xueman Chen et al. NATURE REVIEWS DRUG DISCOVERY
- Exosomes impact survival to radiation exposure in cell line models of nervous system cancer
- (2018) Oliver D. Mrowczynski et al. Oncotarget
- Intraoperative visualization of the tumor microenvironment and quantification of extracellular vesicles by label-free nonlinear imaging
- (2018) Yi Sun et al. Science Advances
- Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression
- (2017) Yu Zhu et al. IMMUNITY
- Cancer-associated mesenchymal stroma fosters the stemness of osteosarcoma cells in response to intratumoral acidosis via NF-κB activation
- (2017) Sofia Avnet et al. INTERNATIONAL JOURNAL OF CANCER
- Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis
- (2017) Elham Safarzadeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Metastasis-specific patterns of response and progression with anti-PD-1 treatment in metastatic melanoma
- (2017) Jenny H. J. Lee et al. Pigment Cell & Melanoma Research
- Metabolic origins of spatial organization in the tumor microenvironment
- (2017) Carlos Carmona-Fontaine et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy
- (2017) Matthias Pinter et al. Science Translational Medicine
- Clinical and molecular features of innate and acquired resistance to anti-PD-1/PD-L1 therapy in lung cancer
- (2017) Shalin Shah et al. Oncotarget
- Clinical Features of Acquired Resistance to Anti–PD-1 Therapy in Advanced Melanoma
- (2017) Daniel Y. Wang et al. Cancer Immunology Research
- Fluorescence-Guided Surgery
- (2017) Tadanobu Nagaya et al. Frontiers in Oncology
- Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
- (2016) Alexander M.M. Eggermont et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade
- (2016) P.-L. Chen et al. Cancer Discovery
- Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer
- (2016) Qingyun Liu et al. Oncotarget
- M2-polarized macrophages contribute to neovasculogenesis, leading to relapse of oral cancer following radiation
- (2016) Makiko Okubo et al. Scientific Reports
- Ionizing radiation affects protein composition of exosomes secreted in vitro from head and neck squamous cell carcinoma
- (2015) Karol Jelonek et al. ACTA BIOCHIMICA POLONICA
- Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia
- (2015) Muhammad Zaeem Noman et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy
- (2015) J. Escamilla et al. CANCER RESEARCH
- The non-targeted effects of radiation are perpetuated by exosomes
- (2015) Ammar Al-Mayah et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Tumour exosome integrins determine organotropic metastasis
- (2015) Ayuko Hoshino et al. NATURE
- Colony stimulating factor 1 receptor inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization
- (2015) Jason H. Stafford et al. NEURO-ONCOLOGY
- T cell exclusion, immune privilege, and the tumor microenvironment
- (2015) J. A. Joyce et al. SCIENCE
- Cancer prevention and therapy through the modulation of the tumor microenvironment
- (2015) Stephanie C. Casey et al. SEMINARS IN CANCER BIOLOGY
- Tumor cell secretion of soluble factor(s) for specific immunosuppression
- (2015) Arihiro Kano Scientific Reports
- Direct Interaction between Carcinoma Cells and Cancer Associated Fibroblasts for the Regulation of Cancer Invasion
- (2015) Hideki Yamaguchi et al. Cancers
- Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer
- (2015) Motohiko Tokuhisa et al. PLoS One
- Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
- (2014) Rakesh K. Jain CANCER CELL
- The tumor microenvironment at a glance
- (2013) F. R. Balkwill et al. JOURNAL OF CELL SCIENCE
- Glutamine and cancer: cell biology, physiology, and clinical opportunities
- (2013) Christopher T. Hensley et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
- (2013) C. Feig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combining two strategies to improve perfusion and drug delivery in solid tumors
- (2013) T. Stylianopoulos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Changes in the local tumor microenvironment in recurrent cancers may explain the failure of vaccines after surgery
- (2012) J. Predina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recruitment of Myeloid but not Endothelial Precursor Cells Facilitates Tumor Regrowth after Local Irradiation
- (2010) S. V. Kozin et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now